Australian
ACL.AXAustralian Clinical Labs Limited Price (ACL.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
199,472,019
(0.8173)%Cash Flow Statement
Australian Clinical Labs LimitedCurrency: AUD
| YEAR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||
| Net Income | -24,031,000.00
+0% |
-9,012,000.00
-62% |
-10,524,000.00
+17% |
41.26M
-492% |
60.37M
+46% |
178.24M
+195% |
35.90M
-80% |
23.93M
-33% |
|||||||||||
| Depreciation And Amortiz... | 12.51M | 11.32M | 11.51M | 77.90M | 88.05M | 106.10M | 122.76M | 128.43M | |||||||||||
| Deferred Income Tax | 0.00 | 0.00 | -30,440,000.00 | -168,009,000.00 | -2,166,000.00 | -1,458,000.00 | -1,883,000.00 | 0.00 | |||||||||||
| Stock-Based Compensat... | 293.00k | 308.00k | 321.00k | 323.00k | 2.17M | 1.46M | 1.88M | 3.06M | |||||||||||
| Change In Working Capital | |||||||||||||||||||
| Accounts Receivables | -958,000.00 | -3,449,000.00 | -3,767,000.00 | -16,803,000.00 | 2.75M | -28,119,000.00 | 17.40M | 0.00 | |||||||||||
| Accounts Payables | 0.00 | 2.16M | -2,917,000.00 | 5.75M | 5.18M | 16.49M | -17,729,000.00 | 0.00 | |||||||||||
| Inventory | -5,000.00 | 573.00k | -423,000.00 | -828,000.00 | -2,261,000.00 | -3,898,000.00 | 5.00M | 0.00 | |||||||||||
| Other Working Capital | 10.20M | -3,446,000.00 | 2.03M | 343.00k | 7.34M | 5.01M | -10,912,000.00 | 487.00k | |||||||||||
| Other Non-Cash Items | 6.59M | 29.90M | 35.33M | 161.80M | -7,565,000.00 | 10.27M | -8,734,000.00 | 3.68M | |||||||||||
| Net Cash Provided By Op... | 4.60M
+0% |
4.69M
+2% |
1.11M
-76% |
101.74M
+9,049% |
153.86M
+51% |
284.09M
+85% |
143.68M
-49% |
159.59M
+11% |
|||||||||||
| Investing Activities | |||||||||||||||||||
| Investments In Propert... | -7,458,000.00 | -8,635,000.00 | -14,362,000.00 | -9,381,000.00 | -9,506,000.00 | -21,252,000.00 | -6,934,000.00 | -6,505,000.00 | |||||||||||
| Acquisitions Net | -4,545,000.00 | 290.00k | 1.37M | 110.00k | 2.36M | -50,791,000.00 | -5,248,000.00 | -1,067,000.00 | |||||||||||
| Purchases Of Investments | 0.00 | -510,000.00 | -527,000.00 | -687,000.00 | -2,364,000.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Sales Maturities Of Inve... | 0.00 | 0.00 | 150.00k | -110,000.00 | 1.07M | 0.00 | 0.00 | 0.00 | |||||||||||
| Other Investing Activities | 90.00k | 290.00k | 303.00k | 110.00k | 2.36M | -51,064,000.00 | -5,484,000.00 | 325.00k | |||||||||||
| Net Cash Used For Inv... | -11,913,000.00
+0% |
-8,855,000.00
-26% |
-13,374,000.00
+51% |
-9,958,000.00
-26% |
-6,076,000.00
-39% |
-72,043,000.00
+1,086% |
-12,182,000.00
-83% |
-7,247,000.00
-41% |
|||||||||||
| Financing Activities | |||||||||||||||||||
| Debt Repayment | -375,000.00 | 1.05M | -7,271,000.00 | -60,916,000.00 | 52.01M | -100,000,000.00 | 66.00M | -11,000,000.00 | |||||||||||
| Common Stock Issued | 0.00 | 0.00 | 14.41M | 0.00 | 146.25M | 0.00 | 0.00 | 0.00 | |||||||||||
| Common Stock Repurch... | 0.00 | -510,000.00 | -527,000.00 | 0.00 | 0.00 | -4,944,000.00 | -891,000.00 | -1,742,000.00 | |||||||||||
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | -42,000,000.00 | -24,218,000.00 | -96,880,000.00 | -19,949,000.00 | |||||||||||
| Other Financing Activities | 13.74M | 3.44M | 17.32M | 0.00 | -303,634,000.00 | -91,748,000.00 | -106,105,000.00 | -113,448,000.00 | |||||||||||
| Net Cash Used/Provide... | 13.37M
+0% |
3.97M
-70% |
9.52M
+140% |
-60,916,000.00
-740% |
-147,370,000.00
+142% |
-220,910,000.00
+50% |
-137,876,000.00
-38% |
-146,139,000.00
+6% |
|||||||||||
| Effect Of Forex Changes... | -5,000.00 | 19.00k | 4.00k | -144,000.00 | -34,000.00 | 5.00k | -40,000.00 | -25,000.00 | |||||||||||
| Net Change In Cash | 6.05M | -169,000.00 | -2,736,000.00 | 30.72M | 384.00k | -8,861,000.00 | -6,417,000.00 | 6.18M | |||||||||||
| Cash At Beginning Of Per... | 985.00k | 7.04M | 6.87M | 4.13M | 34.85M | 35.23M | 26.37M | 19.96M | |||||||||||
| Cash At End Of Period | 7.04M | 6.87M | 4.13M | 34.85M | 35.23M | 26.37M | 19.96M | 26.14M | |||||||||||
| Additional Metrics: | |||||||||||||||||||
| Operating Cash Flow | 4.60M | 4.69M | 1.11M | 101.74M | 153.86M | 284.09M | 143.68M | 159.59M | |||||||||||
| Capital Expenditure | -7,458,000.00 | -8,635,000.00 | -14,362,000.00 | -9,381,000.00 | -9,506,000.00 | -21,252,000.00 | -6,934,000.00 | -6,505,000.00 | |||||||||||
| Free Cash Flow | -2,855,000.00
+0% |
-3,942,000.00
+38% |
-13,250,000.00
+236% |
92.36M
-797% |
144.36M
+56% |
262.84M
+82% |
136.75M
-48% |
153.09M
+12% |
|||||||||||